Persistent Systems (PSYS) Earnings: 4Q Net Income Meets Estimates with 26% Growth

Persistent Systems on Smartkarma

On Smartkarma, analyst Brian Freitas provides insights into the upcoming NIFTY200 Momentum30 Index Rebalance Preview. Forecasting 19 changes for the index in December, Freitas anticipates a one-way turnover of 65.2% amounting to a trade of INR 71bn (US$837m). The potential adds have been outperforming the deletes, with some stocks from new F&O inclusions. Expected on 30 December, the changes could spark significant market movements as the potential inclusions have been showing strong performance compared to the deletions since July.

A look at Persistent Systems Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Investors looking at the long-term prospects of Persistent Systems Limited may find some positive indicators according to Smartkarma Smart Scores. The company has received a solid rating for growth and resilience, with respectable scores for momentum and dividends as well. This suggests that Persistent Systems may have favorable opportunities for expansion and a strong ability to withstand market challenges. With its focus on outsourced software product development, including testing and professional services, the company’s overall outlook appears promising for those considering long-hold investment strategies.

Based on the Smartkarma Smart Scores, Persistent Systems demonstrates strengths in growth, resilience, dividends, and momentum, indicating a well-rounded performance in key areas for investors. The company’s dedication to outsourced software product development, along with its offerings of testing and professional services, positions it as a notable player in the industry. Investors with a focus on long-term investments may view Persistent Systems favorably, considering its positive outlook across multiple factors that contribute to its overall financial health and potential for sustained growth.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma